Zhuxiao Ren

Dr. Zhuxiao Ren


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2018 in Inflammation
Verified
Journal Article
Closed access
PDF file
FXF. Xu
F. Xu
ZRZ. X. Ren
Z. X. Ren
XZX. M. Zhong
X. M. Zhong
QZQ. Zhang
Q. Zhang
JZJ. Y. Zhang
J. Y. Zhang
ZRZhuxiao Ren
Zhuxiao Ren

21 November 2022 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ZRZhuxiao Ren
Zhuxiao Ren
SYShumei Yang
Shumei Yang
JHJiangxue Han
Jiangxue Han
CNChuan Nie
Chuan Nie
CWCuicui Wang
Cuicui Wang
JYJie Yang
Jie Yang

11 September 2020 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
JMJiayu Miao
Jiayu Miao
ZRZhuxiao Ren
Zhuxiao Ren
YRYunbei Rao
Yunbei Rao
XXXin Xia
Xin Xia
JWJianlan Wang
Jianlan Wang
JYJie Yang
Jie Yang
Objective: To investigate the effect of pathological staging of chorioamnionitis (CA) on complications in preterm infants;Methods: A single-center, retrospective study was conducted to choose singleton preterm infants (gestational age < 37 weeks) from the Department of Obstetrics and Gynecology in our hospital from December 2016 to December 2017. The basic data and placental pathological results were retrospectively collected. According to the placental pathological results of whether inflammation infiltrating amnion, CA 0/I phase was classified into non-amnionitis group, CA II/III phase was classified into amnionitis group, the incidence of common complications in preterm infants was compared. Further, logistic regression was used to analyze the effects of amnionitis on complications after being adjusted to gestational age, birth weight and thrombocytopenia.Results: A total of 221 preterm infants were enrolled, including 186 cases in non-amnionitis group and 35 cases in amnionitis group. The gestational age of amnionitis group (32.00 ± 2.71 weeks) was significantly lower than non-amnionitis group (34.14 ± 2.06 weeks), birth weight (1.93 ± 0.64 kg) was significantly lower than that of non-amnionitis group (2.26 ± 0.58 kg), and the hospital stay in amnionitis group was significantly longer (25.71 ± 19.23 days), all of the difference above was statistically significant(P < 0.05). The incidence of intraventricular hemorrhage (IVH) in amnionitis group (37.14%) was significantly higher than that in non-amnionitis group (13.98%) (P = 0.002), and the risk of IVH was significantly increased by amnionitis (OR = 3.636, 95%CI: 1.632–8.102); after correction of gestational age, birth weight and thrombocytopenia, the risk of IVH was still significantly increased (OR = 2.471,P = 0.046, 95% CI: 1.015–6.015). And the late-onset IVH was more common (P = 0.009).Conclusion: Amnionitis leads to a significant reduction in gestational age and birth weight in preterm infants, and it is an independent risk factor for IVH.

8 July 2022 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ZRZhuxiao Ren
Zhuxiao Ren
WMWenhui Mo
Wenhui Mo
LYLiling Yang
Liling Yang
JWJianlan Wang
Jianlan Wang
QZQi Zhang
Qi Zhang
JYJie Yang
Jie Yang
Background: Cathelicidin/LL-37 plays a significant role in the human immune defense reaction. Preterm human immature organs being exposed to inflammation-induced injury was the critical denominator leading to the common preterm associated complications. Previous study showed LL37 concentration in preterm neonates was lower in tracheal aspirates and breast milk as compared to term infants. An adults study showed decreased LL-37 levels was a risk factor for patients in developing severe chronic obstructive pulmonary disease (COPD). However, little is known about the regulation of human cord blood LL37 in preterm neonates and the association with preterm complications. This study was designed to investigate the concentration of LL37 in cord blood of preterm infants and correlation with preterm complications. Methods: Singleton infants born in June 2017 to August 2021 in the study hospital were enrolled. Maternal and neonatal clinical characteristics were collected. LL37 levels, pro-inflammatory factor interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) in cord blood and LL37 levels in serum 48–72 hours after birth were measured by enzyme-linked immunosorbent assay. The serum level of LL37 in preterm and term neonates were compared, the perinatal factors possibly affecting the LL37 levels were investigated and the relationship between LL37 level and preterm outcomes were analyzed. Results: Cord blood LL37 levels in preterm infants were lower than that in term neonates. Cord blood LL37 level was positively correlated with gestational age in preterm. Prenatal steroid administration in preterm neonates decreased cord blood LL37 level. LL37 level was obviously lower in patients with bronchopulmonary dysplasia (BPD). Multiple line regression analysis showed higher LL37 level in cord blood was an independent protective factor for BPD. The concentration of pro-inflammatory factor IL-6 was negatively correlated with LL37. Conclusion: Cord blood LL37 levels increased during gestation and decreased after perinatal steroid usage. Very preterm infants who displayed higher cord blood LL37 level had reduced risk of developing BPD. Regulation of pro-inflammatory cytokine IL-6 may be associated with the protective effect of LL37 on BPD.

17 April 2024 in iScience
Verified
Journal Article
Open access
ZRZhuxiao Ren
Zhuxiao Ren
YSYang Shuo
Yang Shuo
HJHan Jiangxue
Han Jiangxue
PJPei Jingjun
Pei Jingjun
ZQZhang Qi
Zhang Qi
JYJie Yang
Jie Yang
Stem cell therapy may prevent late-onset sepsis (LOS) via antimicrobial peptide LL37 secretion and regulatory T cell (Treg) regulation. The early prediction of LOS is still a challenge. This study evaluated whether immunological state of LL37 or Tregs precedes LOS. We firstly analyzed the LL37 level, Treg proportion, and LOS incidence in very preterm infants treated with autologous cord blood mononuclear cells (ACBMNCs) in our previous trial. Then, we constructed a prediction model and built validation cohort. We found ACBMNC intervention reduced the incidence of LOS from 27.3% to 6.9% (p = 0.021). LL37 and Treg abundances were higher in the ACBMNCs group. The nomogram demonstrated that early-life Treg and LL37 characteristics were closely associated with LOS (area under the curve, AUC 0.936), with implications for early prediction and timely clinical management. This composite model was also helpful to evaluate the beneficial effect of ACBMNCs intervention on LOS, thus promoting translational research.

1 June 2019 in Pediatrics & Neonatology
Verified
Journal Article
Open access
ZRZhuxiao Ren
Zhuxiao Ren
FXF. Xu
F. Xu
ZYZ.W. Yao
Z.W. Yao
BLB.Y. Li
B.Y. Li
YCY.Q. Chang
Y.Q. Chang
JYJ. Yang
J. Yang